You Searched For: Genscript

Catalog Number: (77007-512)

Supplier: Genscript

Description: Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above). It is a recombinant humanized monoclonal antibody. It selectively binds to human immunoglobulin E (IgE). Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. Anti-Omalizumab antibody (15B12), mAb, mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with omalizumab.

Catalog Number: (77007-586)

Supplier: Genscript

Description: Avelumab with trade name Bavencio, is an FDA-approved drug to treat Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). PD-L1 can be highly expressed on certain tumors, which is thought to lead to reduced activation of immune cells (cytotoxic T-cells in particular) that might otherwise recognize and attack the cancer. Inhibition of PD-L1 by Avelumab can remove this inhibitor effect and thereby engender an anti-tumor response. It is one of several ways to block inhibitory signals related to T-cell activation, a more general strategy known as immune checkpoint inhibition. Anti-Avelumab Antibody (12H7), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Avelumab.

Catalog Number: (77007-492)

Supplier: Genscript

Description: Panitumumab with trade name Vectibix, is an FDA-approved drug for the treatment of patients with EGFR-expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens. It is a human monoclonal antibody. Panitumumab binds to the human EGF receptor (EGFR), preventing binding of activating ligands, such as the EGF and transforming growth factor alpha. Anti-Panitumumab antibody (9G12), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with panitumumab.

Supplier: Genscript

Description: The product is specific for SARS-CoV-2 spike protein S1 subunit and its RBD domain.

Supplier: Genscript

Description: The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.

Supplier: Genscript

Description: The product is specific for SARS-CoV-2 spike protein S1 subunit and its RBD domain.

Supplier: Genscript

Description: The product is specific for SARS-CoV-2 spike protein S1 subunit and its RBD domain.

Catalog Number: (76197-302)

Supplier: Genscript

Description: The product is specific for Pembrolizumab. Thisantibody blocks Pembrolizumab binding with human PD-1 recombinant protein(Z03370, PD 1 Fc Chimera, Human) in ELISAs.

Catalog Number: (76197-948)

Supplier: Genscript

Description: WB-MASTER Protein Standard, Designed for convenient protein identification in western blot, Consists of 7 recombinant proteins with MW of 20-120KDa, Volume: 2.5-10 ul/well, the loading volume of the marker should be optimized for different experiments, Size: 250ul

Catalog Number: (76509-896)

Supplier: Genscript

Description: The product is specific for Obinutuzumab. This antibody serves as an excellent positive control for Obinutuzumab immunogenicity (ADA) assays.

Catalog Number: (76509-874)

Supplier: Genscript

Description: The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01922-40, MonoRabTM Anti-Adalimumab Antibody (134D5), mAb, Rabbit.

Catalog Number: (76509-926)

Supplier: Genscript

Description: The product is specific for Atezolizumab. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01948-40, Anti-Atezolizumab Antibody (10G9), mAb, Mouse.

Catalog Number: (77007-516)

Supplier: Genscript

Description: Denosumab with trade name Prolia, is an FDA-approved drug for the treatment of patients with osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is a fully human monoclonal antibody that works as a RANK ligand (RANKL) inhibitor. Denosumab can bind RANKL, preventing RANKL from activating RANK, its receptor on the osteoclast surface. Anti-Denosumab Antibody (2H7), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Denosumab.

Catalog Number: (76510-104)

Supplier: Genscript

Description: The product is specific for sarilumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A02043-40, anti-sarilumab antibody (23H12), mAb, mouse.

Catalog Number: (76509-996)

Supplier: Genscript

Description: The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01984-40, MonoRab anti-atezolizumab antibody (55D8), mAb, rabbit.

Catalog Number: (76197-316)

Supplier: Genscript

Description: GenScript MonoRab™ Rabbit Anti-Camelid VHH Antibody, mAb is specific for Camelid sdAb (Alpaca, Llama and Camel). The monoclonal antibody has no cross-reactivity with mouse, rat, rabbit, chicken, goat or human immunoglobulins.